# Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF

> **NCT06023602** · NA · RECRUITING · sponsor: **Northwest Women's and Children's Hospital, Xi'an, Shaanxi** · enrollment: 1338 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Generic cetrorelix acetate
- **DRUG:** Reference cetrorelix acetate

## Key facts

- **NCT ID:** NCT06023602
- **Lead sponsor:** Northwest Women's and Children's Hospital, Xi'an, Shaanxi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-27
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 1338 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06023602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06023602, "Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06023602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*